Back
Monte Rosa Therapeutics Stock Price Chart
Free Access to "King of the Quants" Stock Rating System
[Claim Your 3 Free Grades Now]
Sell
10
GLUE
Monte Rosa Therapeutics
Last Price:
$5.66
Seasonality Move:
-3.86%
7 Day Trial
ALL ACCESS PASS
$
7
Access "King of the Quants" Stock Rating System FREE!
[Claim Your 3 Free Grades Now]-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLUE is experiencing slight selling pressure.
Monte Rosa Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.89 | Sell |
| 20-day SMA: | 6.56 | Sell |
| 50-day SMA: | 7.93 | Sell |
| 200-day SMA: | 5.89 | Sell |
| 8-day EMA: | 5.99 | Sell |
| 20-day EMA: | 6.59 | Sell |
| 50-day EMA: | 7.13 | Sell |
| 200-day EMA: | 6.38 | Sell |
Monte Rosa Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.6 | Sell |
| Relative Strength Index (14 RSI): | 35.37 | Sell |
| Chaikin Money Flow: | -262945 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.05 - 7.57) | Sell |
| Bollinger Bands (100): | (5.37 - 8.59) | Sell |
Monte Rosa Therapeutics Technical Analysis
| Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Monte Rosa Therapeutics Stock
Is Monte Rosa Therapeutics Stock a Buy?
-
Monte Rosa Therapeutics share price is 5.66 while GLUE 8-day simple moving average is 5.89, which is a Sell signal.
-
The stock price of GLUE is 5.66 while Monte Rosa Therapeutics 20-day SMA is 6.56, which makes it a Sell.
-
Monte Rosa Therapeutics 50-day simple moving average is 7.93 while GLUE share price is 5.66, making it a Sell technically.
-
GLUE stock price is 5.66 and Monte Rosa Therapeutics 200-day simple moving average is 5.89, creating a Sell signal.
GLUE Technical Analysis vs Fundamental Analysis
Sell
10
Monte Rosa Therapeutics (GLUE)
is a Sell
Is Monte Rosa Therapeutics a Buy or a Sell?
-
Monte Rosa Therapeutics stock is rated a SellThe current Monte Rosa Therapeutics [GLUE] share price is $5.66. The Score for GLUE is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
Monte Rosa Therapeutics Stock Info
Market Cap:
347.4M
Price in USD:
5.66
Share Volume:
631.1K
Monte Rosa Therapeutics 52-Week Range
52-Week High:
12.40
52-Week Low:
3.21
Sell
10
Monte Rosa Therapeutics (GLUE)
is a Sell
Monte Rosa Therapeutics Share Price Forecast
-
What is the Monte Rosa Therapeutics stock price today?The Monte Rosa Therapeutics stock price is 5.66 USD today.
-
Will GLUE stock go up or go down?Monte Rosa Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Monte Rosa Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monte Rosa Therapeutics is overvalued.
Is Monte Rosa Therapeutics Stock a Buy?
-
Monte Rosa Therapeutics share price is 5.66 while GLUE 8-day exponential moving average is 5.99, which is a Sell signal.
-
The stock price of GLUE is 5.66 while Monte Rosa Therapeutics 20-day EMA is 6.59, which makes it a Sell.
-
Monte Rosa Therapeutics 50-day exponential moving average is 7.13 while GLUE share price is 5.66, making it a Sell technically.
-
GLUE stock price is 5.66 and Monte Rosa Therapeutics 200-day simple moving average is 6.38, creating a Sell signal.
Fundamental Analysis of Monte Rosa Therapeutics
Is Monte Rosa Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.24 per share.
Technical Analysis of Monte Rosa Therapeutics
Should I short Monte Rosa Therapeutics stock?
-
GLUE Moving Average Covergence Divergence (MACD) indicator is -0.6, suggesting Monte Rosa Therapeutics is a Sell
-
Monte Rosa Therapeutics Relative Strength Index (RSI) is 35.37, which suggest Monte Rosa Therapeutics is oversold
-
The Bollinger Bands (25) for Monte Rosa Therapeutics is (6.05 - 7.57), which suggest Monte Rosa Therapeutics is a Sell
-
The Bollinger Bands (100) for Monte Rosa Therapeutics is (5.37 - 8.59), which suggest Monte Rosa Therapeutics is a Sell
* Monte Rosa Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.